Revolution Medicines Insider Trades
NASDAQ: RVMDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 89 · $79.82M
- Shares bought / sold
- 0 / 390.84K
- Net activity
- Net selling $79.8 million
Revolution Medicines insider activity
Over the last 12 months, Revolution Medicines insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 89 sales. Insiders bought $0 and sold $79.8 million worth of stock, for net insider selling of $79.8 million. The largest seller was GOLDSMITH MARK A, with $20.8 million in reported sales.
The most recent filing shows Sandler Alan B. (Chief Development Officer) reporting a transaction in 6,000 shares at $58.84 on Sep 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RVMD's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RVMD insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Sale | 301 | $61.62K | Form 4 |
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Sale | 1,199 | $244.48K | Form 4 |
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Sale | 1,000 | $202.81K | Form 4 |
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Sale | 1,609 | $324.57K | Form 4 |
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Sale | 2,200 | $441.80K | Form 4 |
| Sep 29, 2026 | Sandler Alan B.Chief Development Officer | Option exercise | 6,000 | $353.04K | Form 4 |
| Sep 25, 2026 | Mancini AnthonySee Remarks | Sale | 3,121 | $625.89K | Form 4 |
| Sep 25, 2026 | Mancini AnthonySee Remarks | Option exercise | 3,121 | $104.93K | Form 4 |
| Sep 25, 2026 | Cislini JeffSVP & General Counsel | Sale | 765 | $158.60K | Form 4 |
| Sep 24, 2026 | Mancini AnthonySee Remarks | Sale | 587 | $117.40K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Sale | 100 | $19.52K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Sale | 1,500 | $291.88K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Sale | 2,648 | $512.23K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Sale | 4,985 | $959.81K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Sale | 910 | $174.59K | Form 4 |
| Sep 22, 2026 | ANDERSON ELIZABETH MDirector | Option exercise | 5,070 | $5.68K | Form 4 |
| Sep 18, 2026 | Mancini AnthonySee Remarks | Sale | 1,764 | $347.40K | Form 4 |
| Sep 16, 2026 | Anders JackChief Financial Officer | Sale | 3,992 | $795.62K | Form 4 |
| Sep 16, 2026 | Anders JackChief Financial Officer | Sale | 61 | $11.89K | Form 4 |
| Sep 16, 2026 | Cislini JeffSVP & General Counsel | Sale | 3,314 | $660.49K | Form 4 |
| Sep 16, 2026 | Cislini JeffSVP & General Counsel | Sale | 52 | $10.14K | Form 4 |
| Sep 16, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 13,775 | $2.75M | Form 4 |
| Sep 16, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 213 | $41.54K | Form 4 |
| Sep 16, 2026 | Mancini AnthonySee Remarks | Sale | 1,747 | $348.18K | Form 4 |
| Sep 16, 2026 | Mancini AnthonySee Remarks | Sale | 27 | $5.27K | Form 4 |
| Sep 16, 2026 | Sandler Alan B.Chief Development Officer | Sale | 336 | $66.97K | Form 4 |
| Sep 16, 2026 | Sandler Alan B.Chief Development Officer | Sale | 5 | $974.79 | Form 4 |
| Sep 16, 2026 | Horn Margaret AChief Operating Officer | Sale | 4,891 | $974.79K | Form 4 |
| Sep 16, 2026 | Horn Margaret AChief Operating Officer | Sale | 76 | $14.82K | Form 4 |
| Sep 16, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 5,484 | $1.09M | Form 4 |
| Sep 16, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 85 | $16.58K | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 3,270 | $672.99K | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 4,995 | $1.02M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 17,949 | $3.66M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 18,869 | $3.83M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 21,447 | $4.33M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 13,368 | $2.68M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 11,833 | $2.37M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Sale | 800 | $158.84K | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Option exercise | 40,031 | $1.63M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen MichaelSee Remarks | Option exercise | 52,500 | $2.23M | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Sale | 300 | $62.15K | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Sale | 1,179 | $242.99K | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Sale | 2,420 | $496.22K | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Sale | 5,530 | $1.13M | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Sale | 6,019 | $1.22M | Form 4 |
| Sep 10, 2026 | Mancini AnthonySee Remarks | Option exercise | 9,363 | $314.78K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 371 | $78.75K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 3,844 | $812.46K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 4,730 | $995.68K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 2,853 | $597.87K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 3,587 | $748.08K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 999 | $207.12K | Form 4 |
| Sep 8, 2026 | Kim Lorence H.Director | Sale | 706 | $145.86K | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 625 | $128.85K | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 2,128 | $436.64K | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 7,271 | $1.49M | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 26,160 | $5.32M | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 12,919 | $2.62M | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 6,597 | $1.33M | Form 4 |
| Aug 31, 2026 | Kim Lorence H.Director | Sale | 300 | $60.17K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 126 | $26.72K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 229 | $48.43K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 126 | $26.51K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 1,405 | $294.02K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 937 | $195.23K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 177 | $36.68K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 127 | $26.93K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 245 | $51.81K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 136 | $28.61K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 1,351 | $282.74K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 951 | $198.15K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 190 | $39.38K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 3,621 | $767.93K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 6,583 | $1.39M | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 3,813 | $801.67K | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 35,938 | $7.52M | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 24,917 | $5.19M | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Sale | 5,128 | $1.06M | Form 4 |
| Aug 21, 2026 | GOLDSMITH MARK ASee Remarks | Option exercise | 80,000 | $378.40K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 3,314 | $702.76K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 4,500 | $951.04K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 2,540 | $534.07K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 25,817 | $5.40M | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 17,323 | $3.61M | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Sale | 3,400 | $704.60K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Option exercise | 26,600 | $574.83K | Form 4 |
| Aug 21, 2026 | Cislini JeffGeneral Counsel | Option exercise | 29,680 | $550.86K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 881 | $169.69K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 541 | $103.80K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 600 | $114.33K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 100 | $18.86K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 300 | $56.35K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 858 | $160.37K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 1,100 | $204.49K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 900 | $166.13K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Sale | 300 | $54.95K | Form 4 |
| Jun 29, 2026 | Patel SushilDirector | Option exercise | 2,955 | $110.93K | Form 4 |
| Jun 24, 2026 | Anders JackChief Financial Officer | Sale | 4,553 | $761.92K | Form 4 |
| Jun 24, 2026 | Anders JackChief Financial Officer | Option exercise | 20,000 | $371.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4